- Telavancin 750mg powder for solution for infusion vials
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Telavancin 750mg powder for solution for infusion vials | Start Date 01-09-2014 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J01XA03
- BNF Codes
-
- BNF code 05010700
Code | Start Date | End Date |
---|---|---|
41882411000001108 | 26-05-2023 | |
443556007 | 01-09-2014 | 25-05-2023 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Telavancin hydrochloride | Based on Base Substance | Telavancin | 750 mg |
Name
Telavancin hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Telavancin
Strength and UOM (Nmr)
750
Strength and UOM (Dmr)
Parent Products
-
VTMTelavancin
-
VMP(Current) Telavancin 750mg powder for solution...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 vial |